|
private:arpeggiobiosciences
|
11472464
|
Apr 21st, 2024 12:00AM
|
Arpeggio Biosciences
|
2.0K
|
17.00
|
Open
|
|
Apr 21st, 2024 05:10AM
|
Apr 21st, 2024 05:10AM
|
Our technology combines a proprietary biological assay and machine learning algorithms that, together, enable rapid, high-resolution snapshots of cellular dynamics following drug treatment. These snapshots are then analyzed to reveal the biological networks that determine a drug’s function and guide therapeutic development.
We are comprised of a talented, diversely-skilled team, working together towards the mission of helping bring new therapies to patients with epigenetically-driven diseases.
|
Open
|
RNA, Machine Learning, Assay Optimization, Statistics, and Next Generation Sequencing
|
Open
|
596 University of Colorado
|
Boulder
|
CO
|
US
|
80309
|
|
Arpeggio Bio
|
|
|
|
private:arpeggiobiosciences
|
11472464
|
Apr 20th, 2024 12:00AM
|
Arpeggio Biosciences
|
2.0K
|
17.00
|
Open
|
|
Apr 20th, 2024 04:10AM
|
Apr 20th, 2024 07:28PM
|
Our technology combines a proprietary biological assay and machine learning algorithms that, together, enable rapid, high-resolution snapshots of cellular dynamics following drug treatment. These snapshots are then analyzed to reveal the biological networks that determine a drug’s function and guide therapeutic development.
We are comprised of a talented, diversely-skilled team, working together towards the mission of helping bring new therapies to patients with epigenetically-driven diseases.
|
Open
|
RNA, Machine Learning, Assay Optimization, Statistics, and Next Generation Sequencing
|
Open
|
596 University of Colorado
|
Boulder
|
CO
|
US
|
80309
|
|
Arpeggio Bio
|
|
|
|
private:arpeggiobiosciences
|
11472464
|
Apr 19th, 2024 12:00AM
|
Arpeggio Biosciences
|
2.0K
|
17.00
|
Open
|
|
Apr 19th, 2024 06:32AM
|
Apr 19th, 2024 06:32AM
|
Our technology combines a proprietary biological assay and machine learning algorithms that, together, enable rapid, high-resolution snapshots of cellular dynamics following drug treatment. These snapshots are then analyzed to reveal the biological networks that determine a drug’s function and guide therapeutic development.
We are comprised of a talented, diversely-skilled team, working together towards the mission of helping bring new therapies to patients with epigenetically-driven diseases.
|
Open
|
RNA, Machine Learning, Assay Optimization, Statistics, and Next Generation Sequencing
|
Open
|
596 University of Colorado
|
Boulder
|
CO
|
US
|
80309
|
|
Arpeggio Bio
|
|
|
|
private:arpeggiobiosciences
|
11472464
|
Apr 18th, 2024 12:00AM
|
Arpeggio Biosciences
|
2.0K
|
17.00
|
Open
|
|
Apr 18th, 2024 05:13AM
|
Apr 18th, 2024 08:47PM
|
Our technology combines a proprietary biological assay and machine learning algorithms that, together, enable rapid, high-resolution snapshots of cellular dynamics following drug treatment. These snapshots are then analyzed to reveal the biological networks that determine a drug’s function and guide therapeutic development.
We are comprised of a talented, diversely-skilled team, working together towards the mission of helping bring new therapies to patients with epigenetically-driven diseases.
|
Open
|
RNA, Machine Learning, Assay Optimization, Statistics, and Next Generation Sequencing
|
Open
|
596 University of Colorado
|
Boulder
|
CO
|
US
|
80309
|
|
Arpeggio Bio
|
|
|
|
private:arpeggiobiosciences
|
11472464
|
Apr 17th, 2024 12:00AM
|
Arpeggio Biosciences
|
2.0K
|
18.00
|
Open
|
|
Apr 17th, 2024 06:32AM
|
Apr 17th, 2024 05:15PM
|
Our technology combines a proprietary biological assay and machine learning algorithms that, together, enable rapid, high-resolution snapshots of cellular dynamics following drug treatment. These snapshots are then analyzed to reveal the biological networks that determine a drug’s function and guide therapeutic development.
We are comprised of a talented, diversely-skilled team, working together towards the mission of helping bring new therapies to patients with epigenetically-driven diseases.
|
Open
|
RNA, Machine Learning, Assay Optimization, Statistics, and Next Generation Sequencing
|
Open
|
596 University of Colorado
|
Boulder
|
CO
|
US
|
80309
|
|
Arpeggio Bio
|
|
|
|
private:arpeggiobiosciences
|
11472464
|
Apr 16th, 2024 12:00AM
|
Arpeggio Biosciences
|
2.0K
|
18.00
|
Open
|
|
Apr 16th, 2024 03:56AM
|
Apr 16th, 2024 01:33PM
|
Our technology combines a proprietary biological assay and machine learning algorithms that, together, enable rapid, high-resolution snapshots of cellular dynamics following drug treatment. These snapshots are then analyzed to reveal the biological networks that determine a drug’s function and guide therapeutic development.
We are comprised of a talented, diversely-skilled team, working together towards the mission of helping bring new therapies to patients with epigenetically-driven diseases.
|
Open
|
RNA, Machine Learning, Assay Optimization, Statistics, and Next Generation Sequencing
|
Open
|
596 University of Colorado
|
Boulder
|
CO
|
US
|
80309
|
|
Arpeggio Bio
|
|
|
|
private:arpeggiobiosciences
|
11472464
|
Apr 15th, 2024 12:00AM
|
Arpeggio Biosciences
|
2.0K
|
18.00
|
Open
|
|
Apr 15th, 2024 06:52AM
|
Apr 15th, 2024 07:13PM
|
Our technology combines a proprietary biological assay and machine learning algorithms that, together, enable rapid, high-resolution snapshots of cellular dynamics following drug treatment. These snapshots are then analyzed to reveal the biological networks that determine a drug’s function and guide therapeutic development.
We are comprised of a talented, diversely-skilled team, working together towards the mission of helping bring new therapies to patients with epigenetically-driven diseases.
|
Open
|
RNA, Machine Learning, Assay Optimization, Statistics, and Next Generation Sequencing
|
Open
|
596 University of Colorado
|
Boulder
|
CO
|
US
|
80309
|
|
Arpeggio Bio
|
|
|
|
private:arpeggiobiosciences
|
11472464
|
Apr 14th, 2024 12:00AM
|
Arpeggio Biosciences
|
2.0K
|
18.00
|
Open
|
|
Apr 14th, 2024 02:41AM
|
Apr 14th, 2024 02:41AM
|
Our technology combines a proprietary biological assay and machine learning algorithms that, together, enable rapid, high-resolution snapshots of cellular dynamics following drug treatment. These snapshots are then analyzed to reveal the biological networks that determine a drug’s function and guide therapeutic development.
We are comprised of a talented, diversely-skilled team, working together towards the mission of helping bring new therapies to patients with epigenetically-driven diseases.
|
Open
|
RNA, Machine Learning, Assay Optimization, Statistics, and Next Generation Sequencing
|
Open
|
596 University of Colorado
|
Boulder
|
CO
|
US
|
80309
|
|
Arpeggio Bio
|
|
|
|
private:arpeggiobiosciences
|
11472464
|
Apr 13th, 2024 12:00AM
|
Arpeggio Biosciences
|
2.0K
|
18.00
|
Open
|
|
Apr 13th, 2024 01:38AM
|
Apr 13th, 2024 01:56PM
|
Our technology combines a proprietary biological assay and machine learning algorithms that, together, enable rapid, high-resolution snapshots of cellular dynamics following drug treatment. These snapshots are then analyzed to reveal the biological networks that determine a drug’s function and guide therapeutic development.
We are comprised of a talented, diversely-skilled team, working together towards the mission of helping bring new therapies to patients with epigenetically-driven diseases.
|
Open
|
RNA, Machine Learning, Assay Optimization, Statistics, and Next Generation Sequencing
|
Open
|
596 University of Colorado
|
Boulder
|
CO
|
US
|
80309
|
|
Arpeggio Bio
|
|
|
|
private:arpeggiobiosciences
|
11472464
|
Apr 12th, 2024 12:00AM
|
Arpeggio Biosciences
|
2.0K
|
18.00
|
Open
|
|
Apr 12th, 2024 01:50AM
|
Apr 12th, 2024 10:59AM
|
Our technology combines a proprietary biological assay and machine learning algorithms that, together, enable rapid, high-resolution snapshots of cellular dynamics following drug treatment. These snapshots are then analyzed to reveal the biological networks that determine a drug’s function and guide therapeutic development.
We are comprised of a talented, diversely-skilled team, working together towards the mission of helping bring new therapies to patients with epigenetically-driven diseases.
|
Open
|
RNA, Machine Learning, Assay Optimization, Statistics, and Next Generation Sequencing
|
Open
|
596 University of Colorado
|
Boulder
|
CO
|
US
|
80309
|
|
Arpeggio Bio
|
|
|